Clinical Trial Update: Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating whether Rabeprazole (E3810) prevents recurrence of gastric or duodenal ulcers in patients taking low-dose aspirin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric or Duodenal Ulcers Caused By Low-dose Aspirin

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Gastric or Duodenal Ulcers Caused by Low-dose Aspirin | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-10-23